Nectar Lifescience Ltd

Nectar Lifesci. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Nectar Lifescience Ltd

₹ 34.6 1.76%
24 Apr - close price
neclife.com BSE: 532649 NSE : NECLIFE
About

Nectar Lifesciences Ltd is primarily engaged in the development, manufacture and marketing of various active pharmaceutical ingredients (APIs) and finished dosage forms.[1]

Key Points

Product Offerings
The company offers high quality cephalosporin intermediates, APIs and Finished dosage formulations (FDF) to meet diverse requirements of its clients. Its key products include Cefixime, Cefuroxime Axetil, Ceftriaxone Sodium and Menthol & its derivatives. [1]

Website BSE NSE
  • Market Cap ₹ 776 Cr.
  • Current Price ₹ 34.6
  • High / Low ₹ 45.7 / 16.4
  • Stock P/E 79.4
  • Book Value ₹ 47.6
  • Dividend Yield 0.00 %
  • ROCE -0.09 %
  • ROE -5.85 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Stock is trading at 0.73 times its book value
  • Debtor days have improved from 84.6 to 67.1 days.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -4.07% over past five years.
  • Company has a low return on equity of -2.92% over last 3 years.
  • Promoters have pledged 100% of their holding.
  • Promoter holding has decreased over last 3 years: -11.4%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
377.98 348.75 384.46 364.57 443.01 476.24 403.03 388.65 344.13 388.81 394.13 397.97 452.17
345.22 319.51 348.82 337.11 396.43 427.09 361.18 396.05 342.69 369.03 358.59 371.11 409.98
Operating Profit 32.76 29.24 35.64 27.46 46.58 49.15 41.85 -7.40 1.44 19.78 35.54 26.86 42.19
OPM % 8.67% 8.38% 9.27% 7.53% 10.51% 10.32% 10.38% -1.90% 0.42% 5.09% 9.02% 6.75% 9.33%
0.66 -24.29 5.15 5.10 0.53 0.52 0.36 10.71 13.24 17.92 0.47 10.61 0.48
Interest 30.63 25.65 25.75 18.01 17.62 17.43 21.37 20.99 17.46 19.66 17.62 20.52 24.84
Depreciation 15.10 15.01 14.28 14.15 14.28 14.26 14.70 14.79 14.78 14.85 15.33 15.31 15.37
Profit before tax -12.31 -35.71 0.76 0.40 15.21 17.98 6.14 -32.47 -17.56 3.19 3.06 1.64 2.46
Tax % 34.52% -14.73% -171.05% -367.50% 36.09% 35.15% 35.99% 30.80% 47.10% -68.03% 40.52% 38.41% 36.18%
-8.06 -40.96 2.07 1.86 9.73 11.66 3.94 -22.47 -9.29 5.36 1.82 1.02 1.57
EPS in Rs -0.36 -1.83 0.09 0.08 0.43 0.52 0.18 -1.00 -0.41 0.24 0.08 0.05 0.07
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
1,312 1,622 1,634 1,638 1,675 1,635 1,873 2,781 2,360 1,539 1,664 1,522 1,633
1,062 1,332 1,345 1,371 1,436 1,411 1,637 2,517 2,142 1,430 1,506 1,467 1,509
Operating Profit 250 290 289 267 239 224 236 264 218 109 159 55 124
OPM % 19% 18% 18% 16% 14% 14% 13% 10% 9% 7% 10% 4% 8%
12 16 12 20 6 23 6 6 4 -22 11 43 29
Interest 115 115 138 126 123 117 115 148 126 112 79 79 83
Depreciation 61 76 84 77 57 62 64 63 61 60 57 59 61
Profit before tax 85 115 78 85 64 67 63 59 36 -85 34 -41 10
Tax % 14% 25% 21% 22% 15% 18% 17% 19% 16% 14% 26% 45%
73 86 62 66 54 55 52 47 30 -73 25 -22 10
EPS in Rs 3.27 3.82 2.77 2.95 2.42 2.46 2.33 2.11 1.34 -3.26 1.13 -1.00 0.44
Dividend Payout % 3% 3% 4% 3% 4% 2% 2% 2% 4% 0% 0% 0%
Compounded Sales Growth
10 Years: -1%
5 Years: -4%
3 Years: -14%
TTM: 1%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 160%
Stock Price CAGR
10 Years: 2%
5 Years: 15%
3 Years: 12%
1 Year: 97%
Return on Equity
10 Years: 3%
5 Years: 0%
3 Years: -3%
Last Year: -6%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 22 22 22 22 22 22 22 22 22 22 22 22 22
Reserves 762 845 905 936 932 984 1,036 1,082 1,112 1,038 1,064 1,042 1,045
1,043 879 858 925 962 878 955 903 779 903 860 754 681
293 527 609 628 640 696 710 696 719 423 443 371 394
Total Liabilities 2,121 2,274 2,394 2,510 2,557 2,581 2,724 2,704 2,632 2,387 2,390 2,189 2,143
858 914 948 934 906 881 852 825 785 772 723 662 826
CWIP 150 139 122 91 99 102 100 100 115 99 85 78 78
Investments 0 0 0 1 1 1 1 1 1 1 1 1 1
1,113 1,221 1,324 1,485 1,551 1,597 1,771 1,778 1,732 1,515 1,580 1,449 1,239
Total Assets 2,121 2,274 2,394 2,510 2,557 2,581 2,724 2,704 2,632 2,387 2,390 2,189 2,143

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
165 361 255 144 169 199 65 239 286 21 95 133
-234 -99 -90 -60 -77 -18 -29 -26 -33 -29 17 52
62 -282 -161 -61 -89 -204 -40 -201 -252 11 -119 -186
Net Cash Flow -7 -20 4 23 3 -24 -4 12 1 4 -8 -0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 85 79 84 99 107 112 119 74 61 89 98 67
Inventory Days 238 216 240 253 260 270 226 150 192 185 197 212
Days Payable 78 122 139 146 154 167 142 79 104 108 112 100
Cash Conversion Cycle 244 172 185 207 213 215 203 145 149 166 183 178
Working Capital Days 190 137 152 173 178 186 190 129 149 190 198 204
ROCE % 12% 13% 12% 11% 10% 10% 9% 10% 8% 3% 5% -0%

Shareholding Pattern

Numbers in percentages

4 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
55.80% 55.80% 55.80% 55.80% 55.80% 55.80% 55.80% 55.80% 55.80% 55.80% 55.80% 55.80%
2.62% 2.46% 1.52% 1.67% 1.49% 16.12% 15.99% 16.07% 16.00% 16.02% 16.12% 16.98%
0.00% 0.00% 0.00% 0.00% 0.00% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%
41.58% 41.74% 42.68% 42.53% 42.72% 28.06% 28.20% 28.12% 28.18% 28.17% 28.05% 27.20%
No. of Shareholders 53,30455,12456,07364,01263,90962,94064,42262,87461,58260,28360,76159,946

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings